Fig. 1.

Considerations in treatment of pLGGs. A representative schematic showing important considerations in pLGG treatment, including understanding the MAPK pathway that altered in most pLGGs and can be targeted using small molecular inhibitors; pre-clinical in vitro and in vivo models; molecular profiling of tumors; and natural history of senescence.